Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
TEVA
$39.53
+0.56%
TEVA
· Teva Pharmaceutical Industries Ltd
Market Cap
$45.67B
Shares
1.17B
Volume · Oct 2
4.77M
Avg daily vol (3M)
5.34M
All webcasts
Earnings call · FY2023 Q3
Teva Pharmaceutical Industries Ltd (TEVA) Q3 2023 Earnings Call
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$3.85B
+7.1% YoY
Diluted EPS
$0.06
+20% YoY
Gross margin
48.1%
+1.7 pp YoY
Net income
$69.00M
+13.1% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Nov 8, 2023.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Tax Rate
table
2023
|
12% – 15% | Non-GAAP |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 8, 2023 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 9, 2023 · complete as-filed document